Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (4980)
Edwards Lifesciences Corp (EW)
Bruls Annette — CVP, EMEACLA
Shares
2,644
Price
$89.98
Total Value
$237.91K
Shares Held After
17,984
% of Holdings
12.8%
PetVivo Holdings, Inc. (PETV)
A.L. Sarroff Fund, LLC — 10% Owner
Shares
580
Price
$0.69
Total Value
$398.46
Shares Held After
10,440,309
% of Holdings
0.0%
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Wambeke David J. — Chief Business Officer
Shares
33,333
Price
$2.01
Total Value
$67.00K
Shares Held After
199,999
% of Holdings
16.7%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
50,000
Price
$0.05
Total Value
$2.50K
Shares Held After
495,400
% of Holdings
10.1%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
78,239
Price
$1.39
Total Value
$108.75K
Shares Held After
689,081
% of Holdings
11.4%
Chemomab Therapeutics Ltd. (CMMB)
Cohen Neil Harris — Director
Shares
1,304
Price
$2.85
Total Value
$3.72K
Shares Held After
34,000
% of Holdings
3.7%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
600,000
Price
$30.34
Total Value
$18.20M
Shares Held After
480,866
% of Holdings
55.5%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
10,000
Price
$8.91
Total Value
$89.10K
Shares Held After
556,887
% of Holdings
1.8%
GRAIL, Inc. (GRAL)
Freidin Aaron — Chief Financial Officer
Shares
7,900
Price
$85.01
Total Value
$671.58K
Shares Held After
253,083
% of Holdings
3.0%
GRAIL, Inc. (GRAL)
Ofman Joshua J. — Director
Shares
5,000
Price
$85.02
Total Value
$425.10K
Shares Held After
397,271
% of Holdings
1.2%
Artiva Biotherapeutics, Inc. (ARTV)
Banerjee Subhashis — Chief Medical Officer
Shares
8,222
Price
$12.01
Total Value
$98.74K
Shares Held After
142,047
% of Holdings
5.5%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
300
Price
$252.76
Total Value
$75.83K
Shares Held After
65,686
% of Holdings
0.5%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
9,259
Price
$251.95
Total Value
$2.33M
Shares Held After
65,986
% of Holdings
12.3%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
19,639
Price
$250.60
Total Value
$4.92M
Shares Held After
75,245
% of Holdings
20.7%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
18,113
Price
$250.02
Total Value
$4.53M
Shares Held After
94,884
% of Holdings
16.0%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
11,423
Price
$248.67
Total Value
$2.84M
Shares Held After
112,997
% of Holdings
9.2%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
18,187
Price
$247.86
Total Value
$4.51M
Shares Held After
124,420
% of Holdings
12.8%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
38,922
Price
$7.20
Total Value
$280.24K
Shares Held After
4,279,426
% of Holdings
0.9%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
38,922
Price
$7.20
Total Value
$280.24K
Shares Held After
4,279,426
% of Holdings
0.9%
Omada Health, Inc. (OMDA)
Cook Steven L. — Chief Financial Officer
Shares
1,108
Price
$25.00
Total Value
$27.70K
Shares Held After
187,209
% of Holdings
0.6%
Camp4 Therapeutics Corp (CAMP)
Schwab Andrew J. — Director
Shares
400,000
Price
$4.04
Total Value
$1.62M
Shares Held After
2,033,270
% of Holdings
16.4%
VEEVA SYSTEMS INC (VEEV)
Schwenger Thomas D. — Pres.&Chief Customer Officer
Shares
10,000
Price
$281.33
Total Value
$2.81M
Shares Held After
19,449
% of Holdings
34.0%
Medpace Holdings, Inc. (MEDP)
Troendle August J. — Director
Shares
650
Price
$620.27
Total Value
$403.18K
Shares Held After
539,894
% of Holdings
0.1%
Cogent Biosciences, Inc. (COGT)
Morris Arlene — Director
Shares
3,161
Price
$37.54
Total Value
$118.66K
Shares Held After
0
% of Holdings
100.0%
Cogent Biosciences, Inc. (COGT)
Morris Arlene — Director
Shares
42,349
Price
$37.09
Total Value
$1.57M
Shares Held After
3,161
% of Holdings
93.1%
METTLER TOLEDO INTERNATIONAL INC/ (MTD)
Kaltenbach Patrick — President and CEO
Shares
942
Price
$1,425.00
Total Value
$1.34M
Shares Held After
4,480
% of Holdings
17.4%
Claritev Corp (CTEV)
Dalton Travis — Director
Shares
4,500
Price
$38.81
Total Value
$174.62K
Shares Held After
50,372
% of Holdings
8.9%
Tonix Pharmaceuticals Holding Corp. (TNXP)
LEDERMAN SETH — Director
Shares
2,000
Price
$13.79
Total Value
$27.58K
Shares Held After
11,005
% of Holdings
18.2%
Jushi Holdings Inc. (JUSH)
Cacioppo James — Director
Shares
500,000
Price
$0.49
Total Value
$245.00K
Shares Held After
4,403,462
% of Holdings
11.4%
Jushi Holdings Inc. (JUSH)
Barack Louis Jon — President
Shares
30,000
Price
$0.50
Total Value
$15.00K
Shares Held After
2,913,773
% of Holdings
1.0%
BIOVIE INC. (BIVI)
DO CUONG V — Director
Shares
15,210
Price
$2.08
Total Value
$31.64K
Shares Held After
16,117
% of Holdings
94.4%
Fulgent Genetics, Inc. (FLGT)
Gao Hanlin — Chief Scientific Officer
Shares
939
Price
$19.91
Total Value
$18.69K
Shares Held After
987,790
% of Holdings
0.1%
Fulgent Genetics, Inc. (FLGT)
Xie Jian — President and COO
Shares
1,193
Price
$19.91
Total Value
$23.75K
Shares Held After
362,051
% of Holdings
0.3%
Arcutis Biotherapeutics, Inc. (ARQT)
Curran Terrie — Director
Shares
27,052
Price
$25.03
Total Value
$677.10K
Shares Held After
23,526
% of Holdings
53.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Curran Terrie — Director
Shares
11,148
Price
$25.03
Total Value
$279.03K
Shares Held After
23,526
% of Holdings
32.2%
FENNEC PHARMACEUTICALS INC. (FENC)
Andrade Robert — CHIEF FINANCIAL OFFICER
Shares
75,000
Price
$11.78
Total Value
$883.50K
Shares Held After
217,675
% of Holdings
25.6%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
610
Price
$72.22
Total Value
$44.05K
Shares Held After
1,336,594
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
11,890
Price
$71.55
Total Value
$850.73K
Shares Held After
1,337,204
% of Holdings
0.9%
DEXCOM INC (DXCM)
Stern Sadie — EVP Chief People&Culture Off
Shares
2,565
Price
$88.37
Total Value
$226.67K
Shares Held After
126,043
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$531.12
Total Value
$63.73K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
755
Price
$530.08
Total Value
$400.21K
Shares Held After
324,563
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,308
Price
$529.15
Total Value
$692.13K
Shares Held After
325,318
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,237
Price
$528.29
Total Value
$653.50K
Shares Held After
326,626
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$526.37
Total Value
$147.38K
Shares Held After
327,863
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
376
Price
$525.62
Total Value
$197.63K
Shares Held After
328,143
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
744
Price
$524.61
Total Value
$390.31K
Shares Held After
328,519
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$523.60
Total Value
$125.66K
Shares Held After
329,263
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$522.40
Total Value
$146.27K
Shares Held After
329,503
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
477
Price
$521.24
Total Value
$248.63K
Shares Held After
329,783
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,003
Price
$520.23
Total Value
$521.79K
Shares Held After
330,260
% of Holdings
0.3%
4980 transactions